TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 40 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $79,000 | -16.8% | 47,455 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | -24.0% | 47,455 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $125,000 | -4.6% | 47,455 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $131,000 | -16.6% | 47,455 | +17.3% | 0.01% | -33.3% |
| Q3 2021 | $157,000 | -40.3% | 40,455 | 0.0% | 0.01% | -40.0% |
| Q2 2021 | $263,000 | -21.0% | 40,455 | 0.0% | 0.02% | -34.8% |
| Q1 2021 | $333,000 | -6.5% | 40,455 | +32.8% | 0.02% | -8.0% |
| Q4 2020 | $356,000 | +126.8% | 30,455 | 0.0% | 0.02% | +92.3% |
| Q3 2020 | $157,000 | +292.5% | 30,455 | +48.9% | 0.01% | +333.3% |
| Q2 2020 | $40,000 | +53.8% | 20,455 | +36.4% | 0.00% | 0.0% |
| Q1 2020 | $26,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |